secwatch / observer
8-K filed October 31, 2023, 7:59 PM ET ticker NEOG CIK 0000711377
other material confidence high sentiment neutral materiality 0.60

Neogen enters new severance agreements, amends bylaws, and holds annual meeting

NEOGEN CORP

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

NEOGEN CORP: Board approved amended and restated bylaws effective October 26, 2023, updating governance provisions including virtual meetings, shareholder nomination procedures, and officer powers (effective 2023-10-26).

Change
bylaw amendment
Effective
2023-10-26
Exact text from the filing
On October 26, 2023, the Board of Directors of the Company approved the amended and restated bylaws (the bylaws, as so amended and restated, the “Amended and Restated Bylaws”), effective immediately.
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

NEOGEN CORP shareholders approved To Approve, by Non-Binding Vote, the Compensation of the Company’s Named Executive Officers at the 2023-10-25 meeting.

Proposal
say on pay
Outcome
passed
Meeting
2023-10-25
Exact text from the filing
Proposal 2 – To Approve, by Non-Binding Vote, the Compensation of the Company’s Named Executive Officers The shareholders approved, by non-binding vote, the compensation of the Company’s named executive officers, as disclosed in the proxy materials. For Against Abstain Broker Non-Vote 188,942,194 6,399,654 294,342 7,464,927
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

NEOGEN CORP shareholders approved Ratification of the Appointment of the Company’s Independent Registered Public Accounting Firm at the 2023-10-25 meeting.

Proposal
auditor ratification
Outcome
passed
Meeting
2023-10-25
Exact text from the filing
Proposal 5 – Ratification of the Appointment of the Company’s Independent Registered Public Accounting Firm The shareholders ratified the appointment of BDO USA, P.A. as the Company’s auditors for the fiscal year ending May 31, 2024. For Against Abstain Broker Non-Vote 192,927,257 10,053,877 119,983 -
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

NEOGEN CORP shareholders approved Election of Directors at the 2023-10-25 meeting.

Proposal
director election
Outcome
passed
Meeting
2023-10-25
Exact text from the filing
Proposal 1 – Election of Directors Nominee For Withheld Aashima Gupta 173,676,074 22,019,553 Raphael A. Rodriguez 187,452,904 8,242,723 Catherine E. Woteki, Ph.D. 190,787,923 4,907,704
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

NEOGEN CORP shareholders approved To Approve the Establishment of the Neogen Corporation 2023 Omnibus Incentive Plan at the 2023-10-25 meeting.

Proposal
equity plan
Outcome
passed
Meeting
2023-10-25
Exact text from the filing
Proposal 4 – To Approve the Establishment of the Neogen Corporation 2023 Omnibus Incentive Plan The shareholders approved the establishment of the Neogen Corporation 2023 Omnibus Incentive Plan, as disclosed in the proxy materials. For Against Abstain Broker Non-Vote 183,704,273 11,662,966 268,951 7,464,927
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

NEOGEN CORP shareholders approved To Approve, on an Advisory Basis, the Frequency of Future Advisory Votes on Executive Compensation at the 2023-10-25 meeting.

Proposal
say on pay frequency
Outcome
passed
Meeting
2023-10-25
Exact text from the filing
Proposal 3 – To Approve, on an Advisory Basis, the Frequency of Future Advisory Votes on Executive Compensation The shareholders approved, on an advisory basis, the frequency of future advisory votes on executive compensation, as disclosed in the proxy materials. 1 Year 2 Years 3 Years Abstain 194,187,940 83,339 1,162,434 202,477
View on SEC.gov

Browse all governance changes →

NEOGEN CORP filing history →

Source: SEC EDGAR
accession 0000950170-23-056922
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.